These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 20558977)

  • 1. Tumor risk in disorders of sex development.
    Pleskacova J; Hersmus R; Oosterhuis JW; Setyawati BA; Faradz SM; Cools M; Wolffenbuttel KP; Lebl J; Drop SL; Looijenga LH
    Sex Dev; 2010 Sep; 4(4-5):259-69. PubMed ID: 20558977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into type II germ cell tumor pathogenesis based on studies of patients with various forms of disorders of sex development (DSD).
    Hersmus R; de Leeuw BH; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Cools M; Looijenga LH
    Mol Cell Endocrinol; 2008 Sep; 291(1-2):1-10. PubMed ID: 18403106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadoblastoma Y locus genes expressed in germ cells of individuals with dysgenetic gonads and a Y chromosome in their karyotypes include DDX3Y and TSPY.
    Vogt PH; Besikoglu B; Bettendorf M; Frank-Herrmann P; Zimmer J; Bender U; Knauer-Fischer S; Choukair D; Sinn P; Lau YC; Heidemann PH; Strowitzki T
    Hum Reprod; 2019 Apr; 34(4):770-779. PubMed ID: 30753444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor risk in disorders of sex development (DSD).
    Looijenga LH; Hersmus R; Oosterhuis JW; Cools M; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2007 Sep; 21(3):480-95. PubMed ID: 17875493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY.
    Kersemaekers AM; Honecker F; Stoop H; Cools M; Molier M; Wolffenbuttel K; Bokemeyer C; Li Y; Lau YF; Oosterhuis JW; Looijenga LH
    Hum Pathol; 2005 May; 36(5):512-21. PubMed ID: 15948118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadal tumours and DSD.
    Looijenga LH; Hersmus R; de Leeuw BH; Stoop H; Cools M; Oosterhuis JW; Drop SL; Wolffenbuttel KP
    Best Pract Res Clin Endocrinol Metab; 2010 Apr; 24(2):291-310. PubMed ID: 20541153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testis-specific protein Y-encoded gene is expressed in early and late stages of gonadoblastoma and testicular carcinoma in situ.
    Li Y; Vilain E; Conte F; Rajpert-De Meyts E; Lau YF
    Urol Oncol; 2007; 25(2):141-6. PubMed ID: 17349529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXL2 and SOX9 as parameters of female and male gonadal differentiation in patients with various forms of disorders of sex development (DSD).
    Hersmus R; Kalfa N; de Leeuw B; Stoop H; Oosterhuis JW; de Krijger R; Wolffenbuttel KP; Drop SL; Veitia RA; Fellous M; Jaubert F; Looijenga LH
    J Pathol; 2008 May; 215(1):31-8. PubMed ID: 18348162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadal development and tumor formation at the crossroads of male and female sex determination.
    Cools M; Wolffenbuttel KP; Drop SL; Oosterhuis JW; Looijenga LH
    Sex Dev; 2011; 5(4):167-80. PubMed ID: 21791949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maturation delay of germ cells in fetuses with trisomy 21 results in increased risk for the development of testicular germ cell tumors.
    Cools M; Honecker F; Stoop H; Veltman JD; de Krijger RR; Steyerberg E; Wolffenbuttel KP; Bokemeyer C; Lau YF; Drop SL; Looijenga LH
    Hum Pathol; 2006 Jan; 37(1):101-11. PubMed ID: 16360422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonadal malignancy in 13 consecutive collected patients with disorders of sex development (DSD) from Semarang (Indonesia).
    Juniarto AZ; Setyawati BA; Miranti IP; Santosa A; Hersmus R; Stoop H; Cools M; Oosterhuis JW; Drop SL; Faradz SM; Looijenga LH
    J Clin Pathol; 2013 Mar; 66(3):198-204. PubMed ID: 23268320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disorder of sex development with germ cell tumors: Which is uncovered first?
    Faure-Conter C; Orbach D; Fresneau B; Verité C; Bonneau J; Thebaud E; Poirée M; Thouvenin S; Pluchart C; Mure PY; Dijoud F; Morel Y
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28169. PubMed ID: 32020769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis.
    Wünsch L; Holterhus PM; Wessel L; Hiort O
    BJU Int; 2012 Dec; 110(11 Pt C):E958-65. PubMed ID: 22540217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent advances in the pathology and classification of gonadal neoplasms composed of germ cells and sex cord derivatives.
    Talerman A; Roth LM
    Int J Gynecol Pathol; 2007 Jul; 26(3):313-21. PubMed ID: 17581418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of neoplasm associated with dysgenetic testes in prepubertal and pubertal/adult patients.
    Slowikowska-Hilczer J; Szarras-Czapnik M; Wolski JK; Oszukowska E; Hilczer M; Jakubowski L; Walczak-Jedrzejowska R; Marchlewska K; Filipiak E; Kaluzewski B; Baka-Ostrowska M; Niedzielski J; Kula K
    Folia Histochem Cytobiol; 2015; 53(3):218-26. PubMed ID: 26314751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor risk and clinical follow-up in patients with disorders of sex development.
    Cools M; Looijenga LH
    Pediatr Endocrinol Rev; 2011 Sep; 9 Suppl 1():519-24. PubMed ID: 22423509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the Y-containing cell line on histological differentiation patterns in dysgenetic gonads.
    Cools M; Boter M; van Gurp R; Stoop H; Poddighe P; Lau YF; Drop SL; Wolffenbuttel KP; Looijenga LH
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):184-92. PubMed ID: 17547684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
    Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
    PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical guide for evaluating gonadal germ cell tumor predisposition in differences of sex development.
    Pyle LC; Nathanson KL
    Am J Med Genet C Semin Med Genet; 2017 Jun; 175(2):304-314. PubMed ID: 28544305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.